Radiofrequency Ablation for Warthin's Tumor

Status Completed

Clinical Trial Summary

This study is a safety and feasibility study to determine if ultrasound guided radiofrequency ablation of parotid Warthin's tumor under local anesthesia is a safe and effective procedure compared to Parotidectomy while using less resources.

Clinical Trial Description

Radiofrequency ablation is minimally invasive and is used in benign disease, including thyroid nodules, head and neck nodules, and vascular malformations, as well as some malignant tumors. For patients unable to or unwilling to undergo surgical resection, real-time ultrasound guided radiofrequency ablation for parotid Warthin's Tumor would be a further option besides observation alone. Twenty patients with Warthin's tumor from the ENT Head and Neck Surgery out-patient clinic at Prince of Wales Hospital will be recruited. The patient will first be asked if they wanted intervention for their condition of Warthin's Tumor. Parotidectomy will first be offered. If the patient opted for intervention but declines parotidectomy, then ultrasound guided RFA will be offered. The 2019 - 2020 Parotidectomy for Warthin's tumor internal audit will be used as a historical comparison to the ultrasound guided RFA group. ;

Study Design

Related Conditions & MeSH terms

Radiofrequency Ablation

Clinical Trial Details

NCT number	NCT05078541
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	October 20, 2021
Completion date	December 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04420013` - Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
Completed	`NCT02382289` - Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points	N/A
Terminated	`NCT06371716` - Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions	N/A
Terminated	`NCT03247413` - Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation	Phase 4
Recruiting	`NCT06033456` - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome	N/A
Not yet recruiting	`NCT05559073` - Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
Recruiting	`NCT06003218` - Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation	N/A
Recruiting	`NCT05500703` - Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia	Phase 4
Completed	`NCT05719948` - Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain	N/A
Completed	`NCT03375281` - Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique	N/A
Recruiting	`NCT05142904` - Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules	Phase 3
Recruiting	`NCT00750711` - Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters	N/A
Recruiting	`NCT02793479` - Radiofrequency Ablation in Patients With Barrett's Esophagus
Completed	`NCT01091597` - Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation	N/A
Not yet recruiting	`NCT04417010` - To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Recruiting	`NCT03067493` - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial	Phase 2
Recruiting	`NCT04471272` - RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes	N/A
Recruiting	`NCT04842253` - HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation.	N/A
Completed	`NCT04801719` - Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis	N/A
Recruiting	`NCT04331184` - RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes	N/A